Miami, FL – June 10, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Glucose Health, Inc. (OTC Pink: GLUC).

PR Newswire

BENTONVILLE, Ark., June 10, 2020

BENTONVILLE, Ark., June 10, 2020 /PRNewswire/ — Glucose Health, Inc. (OTC: GLUC) is pleased to announce that Mr. John Fieldly has accepted an invitation to join the company’s Board of Directors.

Mr. Fieldly is the President and Chief Executive Officer of Celsius Holdings, Inc. (NASDAQ: CELH). Under his leadership, the CELSIUS® brand of functional beverages has enjoyed outstanding growth, along with highly coveted beverage industry recognition.

On May 12, Celsius Holdings, Inc. delivered $28.2 million in revenue for Q1 2020; the best first quarter revenue performance in Company history, up 95% vs. Q1 2019.  CELSIUS® branded products have been the recipients of 22 industry awards, both in the U.S. and globally, including the 2017 Beverage Industry Innovation of the Year Award. 

As the newest member of the Glucose Health, Inc. Board of Directors, Mr. Fieldly commented that, “when I was appointed CEO of Celsius Holdings, Inc. three years ago, I felt that few brands had the growth potential of CELSIUS® and that we were charting a new course for the health and fitness beverage category. GLUCODOWN® has many of the same growth characteristics as CELSIUS® and I am excited to once again, be a part of another small dynamic company with big plans and ambitions.”

Mr. Fieldly added, “GLUCODOWN® is the first iced tea mix infused with healthy soluble fiber, along with essential vitamins and minerals, and offers millions of Americans, particularly those whom are pre-diabetic or diabetic, with a delicious and nutritious beverage choice. Today’s consumer is transitioning to beverages that help promote a healthier lifestyle. The stage is set for GLUCODOWN® to become a category disrupter, much like CELSIUS® when it was first introduced.”

Mr. Fieldly joins Gerry David, who preceded Mr. Fieldly as CEO of Celsius Holdings, Inc. and Hal Kravitz, the former President of the Glaceau business unit at The Coca Cola Company and a current Director of Celsius Holdings, Inc. and Company CEO Murray Fleming, in comprising the Board of Directors of Glucose Health, Inc.

Gerry David commented, “John Fieldly and I both experienced the challenges and ultimate success in bringing CELSIUS® to its position today as a leading functional health and fitness beverage brand.  I am excited to work with John and bring this collective experience to accelerate the growth of GLUCODOWN® into a world-class brand.”

Hal Kravitz, commented, “John Fieldly is a great leader and choice to bring additional experience and corporate depth to our Glucose Health, Inc. Board of Directors. I look forward to collaborating with John to achieve the unique potential of GLUCODOWN® which addresses the clear and growing consumer need for functional diabetic beverage options.”

Murray Fleming, Glucose Health, Inc. CEO, stated, “the success of GLUCODOWN® is premised upon offering outstanding nutritional efficacy and great taste. John Fieldly and his team at Celsius Holdings, Inc. demonstrate the heights of achievement this winning combination can attain.  I am delighted to welcome John to the Board of Directors of Glucose Health, Inc.”  

About Glucose Health, Inc. (OTC: GLUC)

GLUCODOWN® is the premier functional beverage in the diabetic/adult nutrition consumer category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic by the Centers for Disease Control and Prevention.1 GLUCODOWN® Diabetic Friendly Tea Mix includes a unique form of soluble fiber which, nearly 20 years of clinical data2 indicate, is associated with slowing the absorption of dietary sugars, as well as, improved digestive health.  GLUCODOWN® is manufactured in the USA and is a publicly traded company with the ticker symbol (OTC: GLUC).

1National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services.

2For citations see www.glucodown.com/clinical-data

Cision View original content:http://www.prnewswire.com/news-releases/john-fieldly-appointed-to-board-of-directors-of-glucose-health-inc-301072820.html

SOURCE Glucose Health, Inc.

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. EmergingGrowth.com has been compensated four thousand one hundred dollars in consideration for its work with Glucose Health, Inc. through the date this was published. EmergingGrowth.com may or may not receive additional compensation, details about which can be found in our full disclosure, which can be found here https://emerginggrowth.com/4582-6827465/.  You can easily loose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Add a Comment to this Post

comments